Breast cancer (BrCa) preferentially spreads to bone and colonizes within the bone marrow to cause bone metastases. To improve the outcome of patients with breast cancer bone metastasis, we need to understand better the mechanisms underlying bone metastasis. Researchers have relied heavily upon in vivo xenografts due to limited availibility of human bone metastasis samples. A significant limitation of these is that they do not have a human bone microenvironment. To address this issue, we have developed a nanoclay based 3D in vitro model of breast cancer bone metastasis using human breast cancer cells mimicking late stage of breast cancer pathogenesis at the metastatic site. This 3D model can provide a microenvironment suitable for cell‐cell, and cell‐matrix interactions while retaining the behavior of BrCa cells with different metastasis potential (i.e., highly metastatic MDA‐MB‐231, and low metastatic MCF‐7) as shown by the production of alkaline phosphatase (ALP) and matrix metalloproteinase‐9 (MMP‐9). The sequential culture of mesenchymal stem cells (MSCs) with MCF‐7 exhibited 3D tumoroids formation and also occurrence of mesenchymal to epithelial transition of cancer metastasis as evidenced by gene expression and immunocytochemistry. The unique and distinct behavior of highly metastatic MDA‐MB‐231 and the low metastatic MCF‐7 was observed at the bone metastasis site. The changes to migratory capabilities and invasiveness in MDA‐MB‐231 in comparison to tumor growth with MCF‐7 was observed. Together, a novel bone‐mimetic 3D in vitro breast cancer model has been developed that could be used to study mechanisms governing the later stage of cancer pathogenesis in bone.
4 October 2017 in Journal of Tissue Engineering and Regenerative Medicine
Biomaterials selection and design, and mechanical properties evolution during degradation and tissue regeneration play a critical role in the successful design of nanocomposite scaffolds for bone tissue regeneration. A new multiscale mechanics-based in silico approach is developed to provide a robust predictive methodology for nanocomposite scaffolds. Scaffolds are fabricated using amino acid–modified nanoclay with biomineralized hydroxyapatite (in situ HAPclay) and polycaprolactone (PCL). Steered molecular dynamics (SMD) simulations of the molecular models of HAPclay and the PCL composite provide a mechanical response of the material and the nature of the molecular interactions among constituents. The mechanical responses obtained from SMD are incorporated into a finite element (FE) model of a PCL/in situ HAPclay scaffold with its microstructure obtained from microcomputed tomography images. The model is validated using experimental results. The stress–strain response from multiscale models and experiments shows good agreement with the consideration of wall porosity correction. The multiscale models incorporate damage mechanics–based degradation and healing behavior to capture the evolution of the mechanical properties as the scaffolds degrade and human osteoblasts grow and proliferate inside the scaffolds. The novel multiscale models provide a robust prediction of the mechanical properties evolution in the scaffolds over the time evolution of cell growth proliferation and tissue formation.